How do you approach dosing for post-op HNSCC nodal regions with ECE?
This is an area in which the communication between surgeon, pathologist, radiologist, and radiation oncologist is particularly helpful. While our surgeons try to submit nodes with descriptive identification of the nodal level they arise from, it still occasionally happens that we see a pathology report that says "2 of 12 level II-IV nodes involved". When we can (with a high degree of certainty) identify the area of ECE we increase the dose to 66 Gy in 33 fractions (or 63 Gy in 30 fractions) while treating the lower risk areas to 60 Gy in 30 fractions. At this time we continue to struggle with how to use HPV status in this setting. In general, if HPV+ with minimal ECE I am more likely to not increase the dose, especially if i can not localize the position of it.
60 Gy for p16 positive
66 Gy for p16 negative
I do not factor in extent of ENE